Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04641702 · ClinicalTrials.gov registry record · Phase 4
Comprehensive Esophageal Diagnostics Study
A Phase 4 study of Achalasia, sponsored by Emory University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT04641702 is a Phase 4 study of Achalasia that is actively recruiting participants, run by Emory University. The registered enrollment target is 80 participants, below the 130-participant average among 7 other Achalasia trials with a reported enrollment target (38% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04641702, a Phase 4 study of Achalasia, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
The prospective clinical trial will study muscle fibrosis in relation to lower esophageal sphincter (LES) measurements on Functional Lumen Imaging Probe (FLIP) Topography (the novel technology that utilizes impedance planimetry) after pharmacologic challenge. A better understanding of achalasia will allow intervention at an earlier stage.
Conditions Studied
Interventions
- DRUG Atropine challenge
- PROCEDURE Esophageal muscle biopsy
Study Locations (2)
Georgia
- Emory University Hospital - Atlanta
- Emory Saint Joseph's Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-03-17 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04641702
The ClinicalTrials.gov registry entry for NCT04641702 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 130-participant average among 7 other Achalasia trials with a reported enrollment target (38% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Achalasia appearing as the primary indexed condition, and to 2 interventions - of which Atropine challenge is the first listed.
NCT04641702 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT04641702 about?
NCT04641702 is a clinical study titled "Comprehensive Esophageal Diagnostics Study". The prospective clinical trial will study muscle fibrosis in relation to lower esophageal sphincter (LES) measurements on Functional Lumen Imaging Probe (FLIP) Topography (the novel technology that utilizes impedance planimetry) after pharmacologic challenge. A better understanding of achalasia will...
What is the current status of trial NCT04641702?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2021-03-17. Estimated completion is 2026-12-31.
What conditions does trial NCT04641702 study?
This clinical trial studies the following conditions: Achalasia.
What interventions are being tested in trial NCT04641702?
The interventions under investigation include: Atropine challenge (DRUG), Esophageal muscle biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT04641702?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04641702 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Achalasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
VZV in the Enteric Nervous System: Pathogenesis and Consequences
RECRUITING · Phase 4
-
POEM-F for Achalasia International Study
RECRUITING · NA
-
Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
RECRUITING
-
Peroral Endoscopic Myotomy (POEM) for Esophageal Motility
COMPLETED · NA
-
Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia
COMPLETED · NA
-
Short Vs Standard Length Myotomy in Achalasia
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.